vimarsana.com
Home
Live Updates
Nykode Stock Up As FDA Approves IND For VB-C-04 Trial Of VB1
Nykode Stock Up As FDA Approves IND For VB-C-04 Trial Of VB1
Nykode Stock Up As FDA Approves IND For VB-C-04 Trial Of VB10.16 In HPV16-Positive Cervical Cancer
(RTTNews) - Shares of Nykode Therapeutics ASA were gaining around 4 percent in the morning trading in Norway after the company announced that the ...
Related Keywords
Norway ,
Oslo ,
Norwegian ,
Michael Engsig ,
Roche Group ,
Drug Administration ,
Genentech ,
Nykode Therapeutics ,
New York ,